Product Details | DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULE

6505-00-769-2090 00001016505000000

Part Alternates: 6505-00-769-2090, 00-769-2090, 6505007692090, 007692090

Medical, Dental, and Veterinary Equipment and Supplies | Drugs and Biologicals

Supply Group (FSG) NSN Assign. NIIN
65 00-769-2090

Cross Reference | NSN 6505-00-769-2090

Part Number Cage Code Manufacturer
99-0186 89875 DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL
DEXEDRINE SPANSULES 93544 GLAXOSMITHKLINE HOLDINGS AMERICAS INC.
NDC00007-3514-20 93544 GLAXOSMITHKLINE HOLDINGS AMERICAS INC.

Request a Quote

What Our Customers Say

Compare

NSNs for Compare ( up to 4 ): Add 6505-00-769-2090

Technical Data | NSN 6505-00-769-2090

Characteristic Specifications
CAPSULE TYPE ANY ACCEPTABLE
CAPSULE CONTENT FORM ANY ACCEPTABLE
ACTIVE MEDICAMENT MEDICINAL STRENGTH 15.000 MILLIGRAMS DEXTROAMPHETAMINE SULFATE ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE BOTTLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY 50.000
UNIT OF ISSUE WEIGHT 0.13 POUNDS
UNIT OF ISSUE CUBE 0.002 CUBIC FEET
III PART NAME ASSIGNED BY CONTROLLING AGENCY DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES 15MG 50S BT

Restrictions/Controls & Freight Information | NSN 6505-00-769-2090

Category Code Description
Hazardous Material Indicator CodePThere is no information in the HMIS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product
Category Code Description
No Freight Information